AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22384088
Drug: Prolonged administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prolonged administration of recombinant human erythropoietin (rHuEpo) for 16 days.
Trial: 20829661
Drug: Wound cleansing
RxNorm normalized name: Restore Wound Cleansing Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wound cleansing solution containing polihexanide and betaine
Trial: 11489001
Drug: Epirubicin in
RxNorm normalized name: epirubicin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin in combination with carboplatin and paclitaxel (ET-Carbo)
Trial: 7595261
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole 500 mg twice daily for 1 week
Trial: 7595261
Drug: Metronidazole vaginal
RxNorm normalized name: MetroNIDAZOLE Vaginal
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole vaginal gel 0.75% 5 g twice daily for 5 days
Trial: 7595261
Drug: Clindamycin vaginal
RxNorm normalized name: clindamycin Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin vaginal cream 2% 5 g once daily for 7 days
Trial: 2292207
Drug: Ceftriaxone 1
RxNorm normalized name: ceftriaxone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 1 g as a single preoperative dose
Trial: 2292207
Drug: Cefotaxime 1
RxNorm normalized name: cefotaxime 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 1 g preoperative dose plus 9 postoperative doses every 8 h for 3 days
Trial: 7407745
Drug: L-tryptophan (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-tryptophan (6 grams daily)
Trial: 7407745
Drug: Placebo (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (6 grams daily)
Trial: 31551225
Drug: Mucopolysaccharide polysulfate
RxNorm normalized name: Mucopolysaccharide polysulfate
DrugBank: Mucopolysaccharide polysulphate (DB16564)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mucopolysaccharide polysulfate ointment combined with desonide ointment
Trial: 31551225
Drug: Desonide ointment
RxNorm normalized name: Desonide Ointment
DrugBank: Desonide sodium phosphate (DB15835)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desonide ointment only
Trial: 29046015
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (30 mg/kg bolus dose and infusion at 10 mg/kg/h)
Trial: 24631042
Drug: A manihot
RxNorm normalized name: Abelmoschus manihot whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A manihot (huangkui capsule), 2.5 g, 3 times per day
Trial: 24631042
Drug: Losartan potassium,
RxNorm normalized name: Losartan Potassium, 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan potassium, 50 mg/d
Trial: 24631042
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (A manihot + losartan)
Trial: 23115404
Drug: Nightly zolpidem,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nightly zolpidem, 10 mg (5 mg for patients > 60 yrs)
Trial: 19569018
Drug: Oral phosphate
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral phosphate (Pi) load (100 mmol) in NTS group
Trial: 19569018
Drug: Oral phosphate
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral phosphate (Pi) load (100 mmol) in CNT group
Trial: 19569018
Drug: Oral phosphate
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral phosphate (Pi) load (100 mmol) in NTS and CNT groups
Trial: 11473947
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist (ganirelix) during ovarian stimulation for IVF or ICSI
Trial: 8065723
Drug: 0.05% clobetasol
RxNorm normalized name: CLOBETASOL PROPIONATE 0.5 mg in 1 g TOPICAL CREAM [Clobetasol Propionate Cream, 0.05% Clobetasol Propionate Cream, 0.05%]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% clobetasol propionate ointment in orabase
Trial: 8065723
Drug: 0.05% fluocinonide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% fluocinonide ointment in orabase
Trial: 8065723
Drug: Both medications
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both medications (clobetasol propionate and fluocinonide)
Trial: 2115186
Drug: PGI2 (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGI2 (6 ng/kg/min over 8 hours daily for 5 consecutive days)
Trial: 28917370
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no inhalation)
Trial: 25929192
Drug: ALN/D5600 (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALN/D5600 (70 mg/vitamin D3 5600 IU) once weekly
Trial: 25929192
Drug: Calcitriol (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol (0.25 μg/day)
Trial: 20692843
Drug: Arthrocentesis combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arthrocentesis combined with splint therapy
Trial: 20692843
Drug: Rest therapy
RxNorm normalized name: Rest Simply
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rest therapy (restricting mouth opening, analgesic therapy)
Trial: 17764004
Drug: Splint therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Splint therapy
Trial: 11417777
Drug: Nicotine sublingual
RxNorm normalized name: nicotine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine sublingual tablet
Trial: 15571272
Drug: Allopurinol (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (standard treatment)
Trial: 9783530
Drug: Trifazid (fixed-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trifazid (fixed-dose combination of rifampicin, isoniazid, and pyrazinamide)
Trial: 3180489
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) 6.25 mg
Trial: 8583780
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) 25 mg
Trial: 6387965
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) 50 mg
Trial: 5309530
Drug: ID-Jet 1
RxNorm normalized name: Jet Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ID-Jet 1 vaccine (10(7.0) TCID(50)/ml)
Trial: 5309530
Drug: ID-Jet 1a
RxNorm normalized name: Peginterferon Beta-1A
DrugBank: Peginterferon beta-1a (DB09122)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ID-Jet 1a vaccine (10(6.3) TCID(50)/ml)
Trial: 5309530
Drug: ID-Jet 2
RxNorm normalized name: Jet Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ID-Jet 2 vaccine (10(6.0) TCID(50)/ml)
Trial: 29717351
Drug: Colon Capsule
RxNorm normalized name: Sus scrofa colon preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colon Capsule Endoscopy (CCE)
Trial: 31154945
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy (ESCAPE trial)
Trial: 31154945
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy (Quality Improvement and Clinical Research patients)
Trial: 25433572
Drug: Epidural bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural bupivacaine 0.125% with fentanyl 2 μg/mL at 37°C
Trial: 25433572
Drug: Epidural bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural bupivacaine 0.125% with fentanyl 2 μg/mL at 20°C
Trial: 23228072
Drug: Transcription error
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcription error rates for inpatient medications
Trial: 23228072
Drug: Transcription error
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcription error rates for discharge patient medications
Trial: 18771605
Drug: Thiopental (subanaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (subanaesthetic doses)
Trial: 16673208
Drug: Morning insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning insulin glargine plus morning glimepiride (2, 3 or 4 mg)
Trial: 16673208
Drug: Bedtime insulin
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime insulin glargine plus morning glimepiride (2, 3 or 4 mg)
Trial: 15194366
Drug: Daclizumab 1
RxNorm normalized name: daclizumab 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab 1 mg/kg/dose every 14 days for five doses (group I, n = 107)
Trial: 15194366
Drug: Daclizumab 2
RxNorm normalized name: daclizumab 25 MG per 5 ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab 2 mg/kg/dose every 14 days for two doses (group II, n = 112)
Trial: 15194366
Drug: No-antibody induction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-antibody induction (group III, n = 78)
Trial: 11212085
Drug: Spiroflor SRL
RxNorm normalized name: ExoSCRT Derma Signal Kit SRLV KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spiroflor SRL gel (SRL)
Trial: 8280513
Drug: General practitioners'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General practitioners' clinical decision to give thrombolytic therapy
Trial: 2943192
Drug: Midazolam, 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam, 0.2 mg/kg
Trial: 2943192
Drug: Thiopental, 3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental, 3.5 mg/kg
Trial: 27267228
Drug: Topical TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical TXA (1 g)
Trial: 27267228
Drug: Intravenous TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous TXA (1 g)
Trial: 24820653
Drug: Oral alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alendronate (ALN)
Trial: 9004094
Drug: ACE-inhibitor benazepril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE-inhibitor benazepril
Trial: 1804654
Drug: 40 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/kg sodium benzoate
Trial: 1804654
Drug: 80 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/kg sodium benzoate
Trial: 1804654
Drug: 160 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg/kg sodium benzoate
Trial: 1804654
Drug: 80 to
RxNorm normalized name: ALCOHOL 354.4 mL in 80 TOPICAL CLOTH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 to 160 mg/kg sodium benzoate
Trial: 6383991
Drug: Neostigmin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmin (3 x 0.5 mg/die)
Trial: 30832624
Drug: Treatment arm
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment arm with quarterly booster visits for 6 months
Trial: 26702455
Drug: Intranasal atomised
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal atomised dexmedetomidine (DEX) 2 μg/kg
Trial: 24581948
Drug: Noradrenaline infusion
RxNorm normalized name: noradrenaline hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noradrenaline infusion (14 patients)
Trial: 22138037
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy (6 cycles of paclitaxel 70 mg/m(2)/wk [3 weeks on/1 week off])
Trial: 25790233
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg rectal indomethacin
Trial: 1858625
Drug: Heparin pretreatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin pretreatment with treadmill exercise (5000 IU intravenously)
Trial: 1858625
Drug: Heparin calcium
RxNorm normalized name: HEPARIN CALCIUM
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin calcium injections (10,000 IU subcutaneously)
Trial: 31295547
Drug: Stannum metallicum
RxNorm normalized name: Stannum Metallicum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stannum metallicum 30x preparation
Trial: 28276743
Drug: Social modelling
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social modelling (observing positive treatment effects)
Trial: 25621236
Drug: Miconazole cream
RxNorm normalized name: Miconazole Nitrate 2% Topical application Cream [CAREALL MICONAZOLE CREAM]
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole cream
Trial: 18761755
Drug: Cognitive Behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behaviour Therapy (CBT) training for nurses
Trial: 15369420
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of trandolapril (ACE inhibitor) and losartan (ARB)
Trial: 12904684
Drug: Captopril (ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (ACE inhibitor)
Trial: 30442080
Drug: Trandolapril (ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril (ACE inhibitor)
Trial: 8518380
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dobutamine and nitroprusside
Trial: 3088751
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (group 2)
Trial: 3088751
Drug: Standard intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intravenous fluids (group 1)
Trial: 30400222
Drug: 200 mL
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mL of agraz nectar
Trial: 24971661
Drug: AMG 745
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 745 (3 mg/kg)
Trial: 20171425
Drug: Controlled-release (CR)
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release (CR) formulation of simvastatin 40 mg
Trial: 20171425
Drug: Immediate-release (IR)
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release (IR) formulation of simvastatin 40 mg
Trial: 20171425
Drug: Both CR
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both CR and IR formulations
Trial: 14572817
Drug: Intravenous purified,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous purified, pasteurized C1 esterase inhibitor concentrate (Berinert® P) at doses of 500‐1000 IU
Trial: 8753712
Drug: Cefazolin 1
RxNorm normalized name: cefazolin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 1 gram intravenously administered preoperatively and again 15 minutes before skin incision.
Trial: 25764097
Drug: Ototopical and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ototopical and systemic antibiotics
Trial: 15712767
Drug: Poi consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poi consumption (130 g/meal, three times a day for 4 weeks)
Trial: 12908031
Drug: Brazilian DTPw/Hib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brazilian DTPw/Hib combination
Trial: 12908031
Drug: European DTPw/Hib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: European DTPw/Hib combination
Trial: 6645208
Drug: Potassium citrate
RxNorm normalized name: Potassium Citrate
DrugBank: Potassium (DB14500)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Potassium citrate therapy (60 mEq/day)
Trial: 6645208
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate therapy
Trial: 27132200
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mifepristone (200mg oral, 36h before surgery) and misoprostol (400μg oral, 3h before surgery)
Trial: 27132200
Drug: Misoprostol (400μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (400μg oral, 3h before surgery)
Trial: 27132200
Drug: Mifepristone (200mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone (200mg oral, 36h before surgery)
Trial: 27132200
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mifepristone and misoprostol
Trial: 25168098
Drug: Percutaneous coronary
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous coronary intervention (PCI) with second-generation drug-eluting stents (DES) in patients with previous CABG
Trial: 10732318
Drug: Metoclopramide 5
RxNorm normalized name: metoclopramide 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 5 mg
Trial: 15535488
Drug: Metoclopramide 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 2.5 mg
Trial: 11832254
Drug: Individualised educational
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualised educational behavioural treatment delivered by cardiac nurses in hospital
Trial: 8293756
Drug: Sotalol therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol therapy
Trial: 8293756
Drug: Absence of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Absence of prior antiarrhythmic therapy
Trial: 8293756
Drug: Long-term follow-up
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term follow-up of patients discharged on a drug predicted to be effective
Trial: 3720045
Drug: Nifedipine, Metoprolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine, Metoprolol, or Isosorbide Dinitrate (therapy period)
Trial: 3720045
Drug: Placebo (absence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (absence of therapy)
Trial: 16274414
Drug: CRT-D (Cardiac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRT-D (Cardiac Resynchronization Therapy with Defibrillator)
Trial: 19827465
Drug: Caffeine (CAF)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (CAF) 6 mg/kg body mass
Trial: 10486670
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with nitrendipine (10-40 mg/day) possibly associated with enalapril (5-20 mg/day) and/or hydrochlorothiazide (12.5-25 mg/day)
Trial: 8961036
Drug: Moclobemide (300-450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (300-450 mg daily)
Trial: 7593728
Drug: Fluoxetine (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20-40 mg daily)
Trial: 25670364
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human IL-10 injections (subcutaneous)
Trial: 24313693
Drug: Web‐based acceptance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web‐based acceptance and commitment therapy (ACT)
Trial: 11679600
Drug: Fibrin sealant
RxNorm normalized name: FIBRIN SEALANT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin sealant (10 mL sprayed onto the wound before tourniquet deflation and wound closure)
Trial: 8083097
Drug: Accelerated multiple
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated multiple daily fraction radiation (44.40 Gy in 12 fractions, 3.7 Gy BID)
Trial: 2577482
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg nocte for 4 weeks
Trial: 2577482
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg nocte for 4 weeks
Trial: 2577482
Drug: Cimetidine 1600
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine 1600 mg nocte for 4 weeks
Trial: 334210
Drug: Pentazocine 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine 0.6 mg/kg
Trial: 22630616
Drug: Modafinil (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (200 mg for the first 5 days and 100 mg on days 6 and 7)
Trial: 22093474
Drug: DTaP-IPV//PRP-T combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP-IPV//PRP-T combined vaccine (PENTAXIM(TM)) vaccinated at 2, 3, 4 months of age
Trial: 22093474
Drug: DTaP-IPV//PRP-T combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP-IPV//PRP-T combined vaccine (PENTAXIM(TM)) vaccinated at 3, 4, 5 months of age
Trial: 22093474
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: DTaP, Hib tetanus conjugate (Act-HIB(TM)), and IPV (IMOVAX PolioTM(TM)) vaccines vaccinated at 3, 4, 5 months of age
Trial: 22093474
Drug: DTaP-IPV//PRP-T combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP-IPV//PRP-T combined vaccine
Trial: 15209605
Drug: Amantadine 100
RxNorm normalized name: amantadine 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine 100 mg twice daily for 6 months